Abstract
Administration of a Thy-1.2-specific monoclonal antibody to BALB/c mice resulted in a significant decrease in the efficiency of clearance of Candida albicans from the spleen. The rate of clearance of organisms from the spleen of congenic mice was determined by genes in the major histocompatibility complex, as was the magnitude of the inflammatory response in the popliteal lymph node after footpad immunization. These results formally demonstrate the involvement of T cells in host responses to primary candida infection.
Similar content being viewed by others
References
Bistoni, F., Marconi, P., Frati, L., Bonmassor, E., and Garaci, E.: Increase of mouse resistance to Candida albicans infection by thymosin α1. Infect. Immun. 36: 609–614, 1982
Bistoni, F., Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P., and Cassone, A.: Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51: 668–674, 1986
Bodey, G. P.: Candidiasis in cancer patients. Am. J. Med. 2 suppl. 4D: 13–19, 1984
Carrow, E. W. and Domer, J. E.: Immunoregulation in experimental murine candidiasis: Specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49: 172–181, 1985
Cheers, C. and Waller, R.: Activated macrophages in congenitally athymic “nude” mice and in lethally irradiated mice. J. Immunol. 115: 844–847, 1975
Clift, R. A.: Candidiasis in the transplant patient. Am. J. Med. 2 (suppl. 4D): 34–38, 1984
Cutler, J. E.: Acute systemic candidiasis in normal and congenitally thymic deficient (nude) mice. J. Reticuloendothel. Soc. 19: 121–126, 1976
Dausset, J. and Svejgaard, A. (eds.): HLA and Disease, p. 1–316, Munksgaard, Copenhagen, 1977
Giger, R. K., Domer, J. E., and McQuitty, J. T., Jr.: Experimental murine candidiasis: Pathological and immune responses to cutaneous inoculation with Candida albicans. Infect. Immun. 19: 499–509, 1978a
Giger, D. K., Domer, J. E., Moser, S. A., and McQuitty, J. T., Jr.: Experimental murine candidiasis: Pathological and immune responses in T-lymphocyte-depleted mice. Infect. Immun. 21: 729–737, 1978b
Hector, R. F., Domer, J. E., and Carrow, E. W.: Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38: 1020–1028, 1982
Hurtrel, B. and Lagrange, P. H.: Dissociation between cell-mediated immunity and acquired resistance in systemic murine candidiasis. Ann. Immunol. (Paris) 136D: 29–36, 1985
Hurtrel, F., Lagrange, P. H., and Michel, A.: Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunised mice. Infect. Immun. 31: 95–101, 1981
Kirkpatrick, C. H.: Host factors in defense against fungal infections. Am. J. Med. 2 (suppl. 4D): 1–12, 1984
Ledbetter, J. A. and Herzenberg, L. A.: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47: 63–90, 1979
Louria, D. B.: Candida infection in experimental animals In G. P. Bodey and V. Fainstein (eds.): Candidiasis, pp. 29–51, Raven Press, New York, 1985
Maiti, P. K., Kumar, A., Kumar, R., and Mohapatra, L. N.: Role of anti-bodies and effect of BCG vaccination in experimental candidiasis in mice. Mycopathalogica 91: 79–85, 1985
Marra, S. and Balish, E.: Immunity to Candida albicans induced by listeria monocytogenes. Infect. Immun. 10: 72–82, 1974
Miyake, T., Takeyo, K., Nomoto, K., and Muraoka, J.: Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol. Immunol. 21: 703–725, 1977
Odds, F. C.: Candida and Candidosis. University Park Press, Baltimore, 1979
Pearsall, N. N., Adams, B. L., and Bunni, R.: Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol. 120: 1176–1180, 1978
Rifkind, D., Marchioro, T. L., Schneck, S. A., and Hill, R. B.: Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Am. J. Med. 43: 28–38, 1967
Rogers, T. J. and Balish, E.: Immunity to Candida albicans. Microbiol. Rev. 44: 660–682, 1980
Rogers, T. J., Balish, E., and Manning, D. D.: The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 20: 291–298, 1976
Salvin, S. B., Peterson, R. D. A., and Good, R. A.: The role of the thymus in resistance to infection and endotoxin toxicity. J. Lab. Clin. Med. 65: 1004–1022, 1965
Stenderup, A. and Schonheyder, H.: Mycoses complicating AIDS. Microbiol. Sci. 1: 219–223, 1984
Stobo, J., Hull, S., VanScoy, R., and Hermans, P.: Suppressor thymusderived lymphocytes in fungal infection. J. Clin. Invest. 57: 319–328, 1976
Tabeta, H., Mikami, Y., Abe, F., Ommura, Y., and Arai, T.: Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice. Mycopathologica 84: 107–113, 1984
Wade, J. C. and Schimpff, S. C.: Epidemiology and prevention of candida infections. In G. P. Bodey and V. Fainstein (eds.): Candidiasis, pp. 111–133, Raven Press, New York, 1985
Williams, D., Cook, J., Hoffman, E., and Diluzio, N.: Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23: 479–490, 1978
Zinkernagel, R. M., Leist, T., Hengartner, H., and Althage, A.: Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162: 2125–2141, 1985a
Zinkernagel, R. M., Pfau, C. J., Hengartner, H., and Althage, A.: Susceptibility to routine lymphocytic choriomeningitis virus maps to class 1 MHC genes — A model for MHC/disease associations. Nature 316: 814–817, 1985b
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashman, R.B. Mouse candidiasis. Immunogenetics 25, 200–203 (1987). https://doi.org/10.1007/BF00344035
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00344035